Article
Extension of a pilot study: impact from the cytochrome P450 2D6 polymorphism on outcome and costs associated with severe mental illness.
Journal of clinical psychopharmacology - 1 Apr 2000
Chou W H, Yan F X, de Leon J, Barnhill J, Rogers T, Cronin M, Pho M, Xiao V, Ryder T B, Liu W W, Teiling C, Wedlund P J
Abstract excerpt
The influence of cytochrome P450 2D6 (CYP2D6) genetic variability was examined in psychiatric inpatients by evaluating adverse drug events (ADEs), hospital stays, and total costs over a 1-year period in an extension of a previously published brief report. One hundred consecutive psychiatric patients from Eastern State Hospital in Lexington, Kentucky, were genotyped for CYP2D6 expression. ADEs were evaluated by a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.